Implantable patient monitor BIOMONITOR IV

ECGclinicalfor atrial fibrillation

A real challenge exists in the clinical world today with the volume of data generated as more patients benefit from the proven value of long-term cardiac monitoring. Valuable time and resources are spent analyzing false positive arrhythmias, leaving patients waiting for accurate answers. The intelligent technology in BIOMONITOR IV can help. BIOMONITOR IV with SmartECG leverages artificial intelligence (AI) and advanced detection algorithms to reduce 86% of false positives across all major arrhythmias,1 alleviating the review burden and helping clinicians achieve timely and accurate diagnosis to focus on what’s most important – the patient. Product Highlights Intelligent SmartECG AI and advanced detection algorithms reduce 86% of false positives across all major arrhythmias1 to alleviate the review burden Confidence from BIOTRONIK Home Monitoring Streamlined ICM monitoring with indication-specific templates, enhanced automaticity, and intuitive reports Clarity with PVC/PAC Diagnostics The industry’s first to discriminate between PVCs and PACs and clearly report burden over time for personalized treatment decisions Intelligent SmartECG BIOMONITOR IV comes with SmartECG, an intelligent system powered by AI and advanced algorithms to reduce the number of false positive detections for Atrial Fibrillation (AF), Bradycardia, Tachycardia, and Pause.1,2 This allows you to focus on actionable events and spend more time on patient care. SmartECG reduces 86% of false detections across all major arrhythmias while keeping 98% of the clinically relevant episodes.